Mannkind (MNKD) FCF Margin Growth (5y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7,237.00 |
| Dec 31, 2025 | -550.00 |
| Sep 30, 2025 | 11,724.00 |
| Jun 30, 2025 | 198,624.00 |
| Mar 31, 2025 | 6,074.00 |
| Dec 31, 2024 | 6,551.00 |
| Sep 30, 2024 | 737,087.00 |
| Jun 30, 2024 | 1.01 Mn |
| Mar 31, 2024 | 7,561.00 |
| Dec 31, 2023 | -11,743.00 |
| Sep 30, 2023 | 37,263.00 |
| Jun 30, 2023 | 65,596.00 |
| Mar 31, 2023 | 62,166.00 |
| Dec 31, 2022 | 63,817.00 |
| Sep 30, 2022 | 105,589.00 |
| Jun 30, 2022 | -878,979.00 |
| Mar 31, 2022 | -47,705.00 |
| Dec 31, 2021 | 4,420.00 |
| Sep 30, 2021 | -7,708.00 |
| Sep 30, 2017 | 9.71 Mn |